INTIVA BioPharma Inc. is a potentially disruptive drug development company focused on cannabinoid-based pharmaceutical solutions.
The Company is researching and developing drug and cannabinoid molecules for various medical conditions and diseases. ArcView Market Research estimates that America's pharmaceutical cannabis sector could reach over $23 billion by 2020.
Jeffrey Friedland, Chief Executive Officer, and Director
Jeffrey Friedland is the Chief Executive Officer of the Company. He is also the Chief Executive Officer and Chairman of the Board of INTIVA Inc., https://www.intiva.us/ and has served in those positions since the inception of the Company in February 2014. He also is a co-founder of the INTIVA Inc.
Mr. Friedland is a founder of Israel-based, Israel Plant Sciences Ltd., a company that is participating in Israel’s innovative agriculture and medicinal plant sectors and other agricultural related technologies, with a primary focus on cannabis. Mr. Friedland is also a director of CannRx a US-based company with its principal operations in Israel that is researching the medical benefits of cannabis-based pharmaceuticals.
In addition, Jeff is on the Board of Advisors of OWC Pharmaceutical Research Corp. http://www.owcpharma.com/ [symbol : OWCP] an Israeli Medical Research company doing real Marajuana Medical Research and Clinical Trials in Israel. Link to Clinical Trial ... http://tinyurl.com/ycgallvw
In his recently-published second book, "Marijuana: the World's Most Misunderstood Plant",
Mr. Friedland dives into the world of marijuana, discussing the history of the plant,
what we know and what we still hope to discover.
View it on Amazon Books ... http://tinyurl.com/ybsttnwn
Since 1981, Mr. Friedland has provided investment banking, merchant banking, and corporate finance advisory services to hundreds of privately-held and listed companies worldwide. These services have included obtaining venture capital and private equity capital, mergers and acquisitions, and assistance to companies regarding financing their growth and becoming stock market listed on stock exchanges worldwide.
Mr. Friedland has been the chief executive officer and a director of a NASDAQ-listed financial services company, a director, and chairman of the audit committee of a New York Stock Exchange-listed company, and chairman of a company listed on the EU-regulated market of the Frankfurt Stock Exchange.
He is an author, speaker and thought leader on emerging markets, the global economy, and the cannabis industry. He has been featured or quoted in numerous publications including the Wall Street Journal, Reuters, the New York Times, USA Today, the South China Morning Post, the Guam Daily Post, Bloomberg, the Forward, the Jewish Week, Quartz, the Jakarta Globe, Israel Daily Television, BreitBart, NBC.com and Forbes.
Jeffrey Friedland's personal website for his link to his book, his articles and videos: www.jeffreyfriedland.com